HEM1036 Phase 2 Study in Low Anterior Resection Syndrome

Clinical trial NCT05527301 · UNKNOWN

Trial details

NCT number: NCT05527301
Sponsor: HEM Pharma Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

LARS - Low Anterior Resection Syndrome

Start date: 2024-01-01
Primary completion: 2026-01-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.